Chronic Liver Failure Clinical Trial
Official title:
Aerobic Capacity Muscle Strength and Health Related Quality of Life in Children With Chronic Liver Disease
Verified date | January 2024 |
Source | Cairo University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Physical therapy program for children with chronic liver disease consist of gait training, strengthening ex for UL&ll, stretching exercise to improve physical fitness and quality of life
Status | Completed |
Enrollment | 18 |
Est. completion date | June 22, 2023 |
Est. primary completion date | May 22, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 7 Years to 14 Years |
Eligibility | Inclusion Criteria: - Their age ranged from7 to14 years old. - Residence in Cairo to be able to attend the rehabilitation program. - Diagnosis of CLD as (Wilson disease, autoimmune hepatitis, chronic cholestasis , ….etc). - All children were medically stabled - All children had the same socioeconomic status Exclusion Criteria: - Complication that prevent children from performing maximal exercise test as fracture of both upper and lower limbs, cardiovascular instability and muscle disease in patient with glycogen storage disease(GSD) or abnormal creatine phosphokinase(CPK). - Patients with cognitive and motor disorders as in case of hepatic encephalopathy and or ascites. - Patients who underwent liver transplantation. - Patient with end stage liver disease. - History of variceal bleeding from one month ago or less. - No other system disease (chest, cardiac and nervous system). - Medical examination no hernia. |
Country | Name | City | State |
---|---|---|---|
Egypt | Cairo university | Cairo |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Egypt,
Zenith L, Meena N, Ramadi A, Yavari M, Harvey A, Carbonneau M, Ma M, Abraldes JG, Paterson I, Haykowsky MJ, Tandon P. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroen — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | aerobic capacity | it was assessed by 6 minute walk test(6-MWT) in meter, The distance in meters was recorded at the end of the six minutes. | 8week | |
Primary | grip strength | it was assessed by pneumatic hand held dynamometer ,was measured in pounds per square inch (PSI). The child was sitting on a chair with or without arm rest, back supported, and both feet rested on the floor. The right arm was beside the body, with adducted shoulder, elbow flexed 90°, forearm in neutral position, wrist from 0° to 30° extension, and 0° to 15° of ulnar deviation. Child was instructed to hold and compress the pneumatic handle of dynamometer as much strength as possible with the tested hand | 8week | |
Primary | quadriceps strength | it was assessed by Lafayette hand held dynamometer(LHHD)Child position was sitting on chair with back straight, hip and knee were in 90-degree flexion. LHHD was fixed on distal third of anterior surface of child leg while his/her tested thigh was stabilizing and then the child was instructed to perform maximal isometric knee extension and hold for 6 sec against LHHD sensor pad. | 8 week | |
Primary | health related quality of life | The Arabic version of child self-report Pediatric Quality of Life Inventory core scale version 4 (PedsQI) was used to assess HRQOL. PedsQI core scale designed to measure HRQOL in children and adolescents ages from 2 to18years. Each item of the questionnaire rated based on a rating scale from 0-4. Then, each item score was linearly converted on assessment scale from 0 to 100;0=100, 1=75, 2=50, 3=25, 4=0 then overall score calculated for all domains through dividing all answered items over whole number of items, with higher scores indicate a better HRQOL | 8week | |
Primary | fatigue | It was assessed by the PedsQI multidimensional fatigue scale version 3. It is composed of 3 domains; general fatigue, sleep/rest fatigue and cognitive fatigue,Each item score converted on a scale from 0 to 100: 0=100, 1=75, 2=50, 3=25, 4=0 then overall score calculated for all domains through dividing all answered items over whole number of items, with higher scores indicate lower level of fatigue | 8 weeks | |
Secondary | hemoglobin | A blood sample was taken for complete blood count (CBC )hemoglobin | 8week | |
Secondary | liver enzymes | A blood sample was taken for liver enzymes (Total bilirubin ,Direct bilirubin ) unit of measure (mg/dl) | 8week | |
Secondary | minerals | A blood sample was taken for minerals concentration (sodium Na,potassium K, magnissium M, calciumCa, posphorus P and create) unit of measure (mmol/l) | 8week | |
Secondary | mid upper arm circumference in centimeter | assessed by tape measure,the tape was passed around the arm at the mid-point of the upper right arm halfway between the acromion process and the olecranon process | 8 weeks | |
Secondary | triceps skin fold thickness | it was assessed by holtain skinfold calipers in millimeter | 8 weeks | |
Secondary | height in meter (m) | assessed by stadiometre | 8 weeks | |
Secondary | weight in kilogrms (Kg) | assess by electronic scale | 8 weeks | |
Secondary | body mass index | height/weight kg/m2 | 8weeks | |
Secondary | mid upper muscle circumference | assessed by calculators that substract triceps skin fold thickness from mid upper arm circumference | 8weeks | |
Secondary | mid upper leg circumference in centimetre | assessed by tape measure at mid -point between iliac crest and mid of patella | 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04546048 -
The Early Strength Training Program in Post-transplant Liver Cases
|
N/A | |
Recruiting |
NCT05107271 -
Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease
|
||
Completed |
NCT04143230 -
Identification of In-hospital Patients in Need of Palliative Care Using a New Simplified Screening Tool
|
N/A | |
Not yet recruiting |
NCT05727722 -
Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure Adults
|
Phase 1 | |
Completed |
NCT01872767 -
Spectrum, Profile and Outcome of Infections in Patients With Cirrhosis and/ or Acute on Chronic Liver Failure
|
N/A | |
Recruiting |
NCT04335058 -
Lactoferrin in Treatment of Fe Deficient Anemia In Cirrhosis
|
N/A | |
Completed |
NCT02691533 -
To Study the Immunomodulating Effects and Safety Profile of ω3 and ω6 PUFA Containing Intravenous Lipid Emulsion in Patients With Acute on Chronic Liver Failure
|
N/A |